NORDIC BIOTECH GENERAL PARTNER ApS: Financial statements 2021
CVR: 26270367
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
NORDIC BIOTECH GENERAL PARTNER ApS (CVR 26270367) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 15,750 and a net result of DKK 7,716 compared with DKK -784,289 the year before. Equity in the 2021 report amounted to DKK 929,667. The solvency ratio was 98.1%.
- Gross Profit
- DKK 15,750
- Profit/Loss
- DKK 7,716
- Equity
- DKK 929,667
- Total Assets
- DKK 947,417
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 16K | 8K | 930K | 0 |
| 2020 | - | -765K | -784K | 922K | - |
| 2019 | - | 16K | 7K | 1.7M | - |
| 2018 | - | -417K | -421K | 1.7M | 0 |
| 2017 | - | 2.4M | 1.8M | 2.1M | - |
Official annual report
Find more companies like NORDIC BIOTECH GENERAL PARTNER ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
NORDIC BIOTECH GENERAL PARTNER ApS has published its annual report for 2020. Gross profit came to DKK -765,000, and the net result was DKK -784,289.
About NORDIC BIOTECH GENERAL PARTNER ApS
NORDIC BIOTECH GENERAL PARTNER ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company is owned by TECH GROWTH INVEST ApS and C. HANSEN INVEST ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 163,699 and a net result of DKK 178,169 compared with DKK 67,346 the year before. Equity in the 2025 report amounted to DKK 1,214,065.